Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

PXI URCD

K-Number: K913435 · 1992-11-05

Decision Date1992-11-05
Product CodeKPR
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

PXI URCD is the device name listed in this FDA 510(k) record. The listed applicant is Brotherston/Pxi. It received FDA 510(k) clearance on 1992-11-05 under 510(k) number K913435. The device is classified under product code KPR. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the PXI URCD?

PXI URCD is a medical device that received FDA 510(k) clearance on 1992-11-05. The listed applicant is Brotherston/Pxi. The 510(k) number is K913435.

When did PXI URCD receive FDA 510(k) clearance?

PXI URCD received FDA 510(k) clearance on 1992-11-05, under 510(k) number K913435.

Who is the listed applicant for PXI URCD?

The FDA 510(k) record lists Brotherston/Pxi as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for PXI URCD?

The FDA product code for PXI URCD is KPR.

Other records listing Brotherston/Pxi as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: KPR)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑